These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
244 related items for PubMed ID: 3938250
1. [Contraception in the hypertensive woman using a vaginal ring delivering estradiol and norgestrel]. Elkik F, Basdevant A, Corvol P. Arch Mal Coeur Vaiss; 1985 Oct; 78(11):1737-9. PubMed ID: 3938250 [Abstract] [Full Text] [Related]
2. Contraception in hypertensive women using a vaginal ring delivering estradiol and levonorgestrel. Elkik F, Basdevant A, Jackanicz TM, Guy-Grand B, Mercier-Bodard C, Conard J, Bardin CW, Corvol P. J Clin Endocrinol Metab; 1986 Jul; 63(1):29-35. PubMed ID: 3086360 [Abstract] [Full Text] [Related]
3. [Vaginal ring contraception in hypertensive women]. Basdevant A, Elkik F, Guy-grand B, Conard J, Corvol P. Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):365-7. PubMed ID: 12280208 [Abstract] [Full Text] [Related]
4. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen. Sitruk-Ware RL, Menard J, Rad M, Burggraaf J, de Kam ML, Tokay BA, Sivin I, Kluft C. Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148 [Abstract] [Full Text] [Related]
7. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring. Roy S, Mishell DR, Gray G, Dozono-Takano R, Brenner PF, Eide I, de Quattro V, Shaw ST. Am J Obstet Gynecol; 1980 Apr 01; 136(7):920-31. PubMed ID: 6767404 [Abstract] [Full Text] [Related]
8. [Influence of progestins on adverse effects of oral contraceptives]. Wynn V. Contracept Fertil Sex (Paris); 1985 Jan 01; 13(1 Suppl):425-30. PubMed ID: 12280210 [Abstract] [Full Text] [Related]
9. Progestogen contraception using chlormadinone acetate in women presenting high vascular risk. (A gynecoendocrine, metabolic and vascular study). Pelissier C, Basdevant A, Conard J, Egloff M, Husson T, Guyenne TT. Contracept Fertil Sex (Paris); 1987 Jan 01; 15(1):45-54. PubMed ID: 12315161 [Abstract] [Full Text] [Related]
10. [Pros and cons of triphasic oral contraception]. Berdah J. Contracept Fertil Sex (Paris); 1985 Dec 01; 13(12):1205-10. PubMed ID: 12267512 [Abstract] [Full Text] [Related]
13. [Post-coital contraception]. Serfaty D. Contracept Fertil Sex (Paris); 1985 Jan 01; 13(1 Suppl):359-64. PubMed ID: 12280207 [Abstract] [Full Text] [Related]
14. Current status of research and development of vaginal contraceptive rings as a fertility control method in the female. Roy S, Mishell Dr. Res Front Fertil Regul; 1983 May 01; 2(4):1-10. PubMed ID: 12227323 [Abstract] [Full Text] [Related]
15. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study. Chompootaweep S, Nunthapisud P, Trivijitsilp P, Sentrakul P, Dusitsin N. Clin Pharmacol Ther; 1998 Aug 01; 64(2):204-10. PubMed ID: 9728901 [Abstract] [Full Text] [Related]
16. [Metabolic risks of oral contraception]. Monier L. Rev Int Pediatr; 1988 Feb 01; (178):64-5. PubMed ID: 12282576 [Abstract] [Full Text] [Related]
17. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data]. Gaspard U, Dubois M. Contracept Fertil Sex (Paris); 1982 Sep 01; 10(9):551-60. PubMed ID: 12311606 [Abstract] [Full Text] [Related]
19. [Choice of contraception for the diabetic woman]. Athea N, Kuttenn F. Journ Annu Diabetol Hotel Dieu; 1983 Feb 01; ():253-61. PubMed ID: 6358615 [Abstract] [Full Text] [Related]
20. A new ultra-low-dose combination oral contraceptive. Woutersz TB. J Reprod Med; 1983 Jan 01; 28(1 Suppl):81-4. PubMed ID: 6403705 [Abstract] [Full Text] [Related] Page: [Next] [New Search]